This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Regeneran Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 49 
1 out of 1,482 
Years Active: 2023-2025
Title: Jie Dai: Innovator in IL10 Agonists
Introduction
Jie Dai is a prominent inventor based in Yorktown Heights, NY (US). He has made significant contributions to the field of therapeutic innovations, particularly in the development of IL10 agonists. With a total of 2 patents, his work focuses on enhancing anti-tumor therapeutic efficacy.
Latest Patents
Dai's latest patents include innovative IL10 agonists and methods of use thereof. The present disclosures relate to IL10 agonists that feature an IgG Fc domain, a linker moiety, and an IL10 moiety. These advancements aim to improve the therapeutic efficacy against tumors, showcasing the potential of IL10 agonists in cancer treatment.
Career Highlights
Throughout his career, Jie Dai has worked with notable companies such as Regeneron Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Some of his coworkers include Maria Del Pilar Molina-Portela and Ella Ioffe. Their collaborative efforts have furthered the research and application of IL10 agonists in therapeutic settings.
Conclusion
Jie Dai's innovative work in the field of IL10 agonists represents a significant advancement in cancer therapy. His contributions continue to influence the development of effective treatments for tumor-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile